Adcock Ingram began as the EJ Adcock Pharmacy in Krugersdorp 119 years ago. Adcock was listed on the main trading board of the JSE in 1950 before it became a wholly-owned subsidiary of Tiger Brands and was subsequently delisted from the JSE in 2000. Adcock Ingram then listed back on the main board of the JSE on August 25, 2008 at a share price of R33.50 with approximately 172.6 million ordinary shares in issue.

The company has a market capitalisation of about R8 billion and occupies a 10% share of the private pharmaceutical industry in South Africa. The unbundling from Tiger Brands and subsequent listing presented Adcock with opportunities that enabled it to drive its vision of being recognised as a leading, world-class, branded healthcare company. The company looks forward to pursuing organic growth opportunities and acquisitions in selected markets, developing exportable competencies, and implementing meaningful Broad Based Black Economic Empowerment (BBBEE) within the business.

Corporate Video

The company has a number of divisions; each delivering essential services to a wide customer base:

Pharmaceutical Business

Adcock Ingram provides an extensive portfolio of branded and generic medicines in the following health disciplines – cardiovascular; central nervous system; dermatology; diabetes; ear, nose and eye preparations; feminine health; and analgesics. Its prescription brands include Myprodol and Synap Forte. It also has a strong presence in the Over the counter (OTC) market, where an independent industry analysis has shown that every second OTC brand sold in South Africa is an Adcock Ingram product. The portfolio range in the OTC market includes therapeutic products for coughs, colds, flu and analgesics. Some of the leading brands include Corenza C, Panado, Vita-thion, and Bioplus.

Hospital Products

Adcock Ingram Critical Care, is South Africa's largest supplier of hospital and critical-care products, blood systems and accessories as well as products used for renal dialysis and transplant medication. This business unit has a 60 year relationship with US-based Baxter International. Adcock Ingram through the Scientific Group, also supplies established brand name consumables and equipment to medical, research and pathology laboratories.